Actively Recruiting

Phase Not Applicable
Age: 40Years +
All Genders
NCT06488248

Endoscopic Third Ventriculostomy vs. Ventriculoperitoneal Shunt in Idiopathic Normal Pressure Hydrocephalus (ENDOVEST)

Led by University Hospital, Basel, Switzerland · Updated on 2025-02-03

150

Participants Needed

1

Research Sites

180 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The aim of this single-center, two-arm, open-labeled, randomized controlled clinical study is to compare two surgical interventions, endoscopic third ventriculostomy and ventriculoperitoneal shunt, in treating idiopathic normal pressure hydrocephalus in terms of clinical improvement.

CONDITIONS

Official Title

Endoscopic Third Ventriculostomy vs. Ventriculoperitoneal Shunt in Idiopathic Normal Pressure Hydrocephalus (ENDOVEST)

Who Can Participate

Age: 40Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Over 40 years of age
  • Symptoms lasting at least 3 months but less than 24 months
  • No history of head trauma, brain hemorrhage, meningitis, or other secondary hydrocephalus causes
  • Must have gait or balance disturbance plus cognitive impairment and/or urinary problems
  • Ventricular enlargement (Evans Index > 0.3) not due to brain atrophy or congenital enlargement
  • No visible blockage of cerebrospinal fluid flow
  • Opening pressure less than 24 cmH2O when lying on the side
  • Clinical improvement in at least one main symptom after removing 40-50 ml of cerebrospinal fluid
Not Eligible

You will not qualify if you...

  • Age 40 years or younger
  • No informed consent provided
  • Other neurological, psychiatric, or general medical condition explaining symptoms
  • Previous brain surgery
  • Other types of dementia
  • Unable to walk
  • Pregnant or breastfeeding women

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of Neurosurgery, University Hospital of Basel

Basel, Switzerland, 4031

Actively Recruiting

Loading map...

Research Team

F

Florian Marc Ebel, Dr. med.

CONTACT

R

Raphael Guzman, Prof. Dr. med.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here